Ascend Gene & Cell Therapies
Latest round
- Series A
Last raised
- Feb 2023
Total raised
- $67M
Investors
- 8
About Ascend Gene & Cell Therapies
Based in London, UK, and founded by Tim Funnell (Executive Director) in 2021, Ascend Gene & Cell Therapies Ltd. operates as a gene and cell therapy developer for biotech companies. The company serves as a fully integrated partner for gene therapy development and manufacturing including material, process and formulation development, clinical manufacturing, and analytical and regulatory support. The company's core offering is centered around the field of adeno-associated virus (AAV) platform technologies including CMC development capabilities, end-to-end service including cassette optimization, screening, and starting material to process, formulation, and analytical development, and analytical toolkit with 60 assays across process and product characterization, In-Process Control (IPC), quality control (QC) and stability. Ascend's expertise also extends to regulatory matters, including EMA or FDA filing requirements, providing support to clients throughout the regulatory process.
Who invested in Ascend Gene & Cell Therapies
8 investors across 1 round
See all investors in Ascend Gene & Cell Therapies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Feb 7, 2023
Amount
$67M
Investors
Questions about Ascend Gene & Cell Therapies
Who invested in Ascend Gene & Cell Therapies?
Ascend Gene & Cell Therapies has 8 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ascend Gene & Cell Therapies raised?
Ascend Gene & Cell Therapies has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Ascend Gene & Cell Therapies last raise money?
Ascend Gene & Cell Therapies's most recent round on record is a Series A, in Feb 2023.
What does Ascend Gene & Cell Therapies do?
Based in London, UK, and founded by Tim Funnell (Executive Director) in 2021, Ascend Gene & Cell Therapies Ltd.
Where is Ascend Gene & Cell Therapies headquartered?
Ascend Gene & Cell Therapies is headquartered in Cheshire, UK.
Which VCs invest in companies like Ascend Gene & Cell Therapies?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Ascend Gene & Cell Therapies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Ascend Gene & Cell Therapies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.